难治性-话题@MedSci

#难治性#

683篇内容 | 2674人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528422, encodeId=87e1152842254, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。, objectType=article, longId=123306, objectId=4e3712330674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e3712330674, replyNumber=0, likeNumber=71, createdTime=2017-12-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e3712330674, moduleTitle=Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e3712330674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528421, encodeId=70eb1528421bb, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】II期临床结果表明伊布替尼联合Venetoclax 对复发难治性以及遗传高风险CLL患者效果显著, objectType=article, longId=122976, objectId=1b1f1229e69f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b1f1229e69f, replyNumber=0, likeNumber=43, createdTime=2017-12-12, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b1f1229e69f, moduleTitle=【2017 ASH】II期临床结果表明伊布替尼联合Venetoclax 对复发难治性以及遗传高风险CLL患者效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b1f1229e69f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528420, encodeId=52c8152842096, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】CLARITY研究——伊布替尼联合Venetoclax疗法对复发难治性CLL患者疗效喜人, objectType=article, longId=122975, objectId=1c8b1229e548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c8b1229e548, replyNumber=0, likeNumber=40, createdTime=2017-12-12, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8b1229e548, moduleTitle=【2017 ASH】CLARITY研究——伊布替尼联合Venetoclax疗法对复发难治性CLL患者疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c8b1229e548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528419, encodeId=7314152841912, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017ASH】PA分析——伊布替尼治疗复发/难治性套细胞淋巴瘤中位随访时间3.5年, objectType=article, longId=122937, objectId=5e1a12293e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e1a12293e5c, replyNumber=0, likeNumber=0, createdTime=2017-12-12, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e1a12293e5c, moduleTitle=【2017ASH】PA分析——伊布替尼治疗复发/难治性套细胞淋巴瘤中位随访时间3.5年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1a12293e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528418, encodeId=638c152841889, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】伊布替尼治疗复发/难治性套细胞淋巴瘤的长期随访研究, objectType=article, longId=122933, objectId=d3461229331a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3461229331a, replyNumber=0, likeNumber=52, createdTime=2017-12-12, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3461229331a, moduleTitle=【2017 ASH】伊布替尼治疗复发/难治性套细胞淋巴瘤的长期随访研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3461229331a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528417, encodeId=e799152841e49, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAHA：难治性高血压的患病率和临床特点分析！, objectType=article, longId=122743, objectId=546b122e432a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546b122e432a, replyNumber=0, likeNumber=69, createdTime=2017-12-10, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546b122e432a, moduleTitle=JAHA：难治性高血压的患病率和临床特点分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546b122e432a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528416, encodeId=617715284165b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估, objectType=article, longId=122544, objectId=343112254479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343112254479, replyNumber=0, likeNumber=66, createdTime=2017-12-08, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343112254479, moduleTitle=【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=343112254479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528415, encodeId=265c15284150b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=NEJM：重症难治性哮喘治疗进展！, objectType=article, longId=121846, objectId=3bb312184693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bb312184693, replyNumber=0, likeNumber=60, createdTime=2017-12-01, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bb312184693, moduleTitle=NEJM：重症难治性哮喘治疗进展！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bb312184693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528414, encodeId=eee5152841430, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Respir Med：支气管热成型术治疗和生物治疗可治疗重症难治性哮喘！, objectType=article, longId=121842, objectId=0d3e12184250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d3e12184250, replyNumber=0, likeNumber=99, createdTime=2017-12-01, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d3e12184250, moduleTitle=Lancet Respir Med：支气管热成型术治疗和生物治疗可治疗重症难治性哮喘！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d3e12184250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528413, encodeId=6740152841301, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAHA：胸段硬膜外麻醉可作为难治性室速的治疗选择, objectType=article, longId=121071, objectId=9b341210e116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b341210e116, replyNumber=0, likeNumber=0, createdTime=2017-11-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b341210e116, moduleTitle=JAHA：胸段硬膜外麻醉可作为难治性室速的治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b341210e116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528412, encodeId=9bf515284124f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=难治性高血压患者的新出路, objectType=article, longId=120938, objectId=0933120938f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0933120938f6, replyNumber=0, likeNumber=89, createdTime=2017-11-23, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0933120938f6, moduleTitle=难治性高血压患者的新出路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0933120938f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528411, encodeId=613a152841132, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=病例分享： “微”“难”之处显身手：尼可地尔缓解难治性心绞痛两例, objectType=article, longId=120666, objectId=3db112066639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3db112066639, replyNumber=0, likeNumber=71, createdTime=2017-11-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3db112066639, moduleTitle=病例分享： “微”“难”之处显身手：尼可地尔缓解难治性心绞痛两例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3db112066639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528410, encodeId=424e1528410e9, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Chest：氯法齐明治疗原发性和难治性非结核分枝杆菌感染效果如何？, objectType=article, longId=120564, objectId=f8c4120564ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8c4120564ae, replyNumber=0, likeNumber=94, createdTime=2017-11-19, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8c4120564ae, moduleTitle=Chest：氯法齐明治疗原发性和难治性非结核分枝杆菌感染效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8c4120564ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528409, encodeId=d620152840996, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, objectType=article, longId=120438, objectId=26471204387a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26471204387a, replyNumber=0, likeNumber=64, createdTime=2017-11-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26471204387a, moduleTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26471204387a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528408, encodeId=4d87152840891, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Eur J Cancer：健康生活品质得分与去势难治性前列腺癌治疗临床结果相关性分析, objectType=article, longId=119763, objectId=a4bb119e63fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4bb119e63fe, replyNumber=0, likeNumber=97, createdTime=2017-11-14, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4bb119e63fe, moduleTitle=Eur J Cancer：健康生活品质得分与去势难治性前列腺癌治疗临床结果相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4bb119e63fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528407, encodeId=f4e2152840eda, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=BMJ：1995~2015英国难治性高血压的患病和发病趋势如何？, objectType=article, longId=119402, objectId=c0b811940233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0b811940233, replyNumber=0, likeNumber=61, createdTime=2017-11-11, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0b811940233, moduleTitle=BMJ：1995~2015英国难治性高血压的患病和发病趋势如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0b811940233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528406, encodeId=4a001528406de, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Nat commun：在去势难治性前列腺癌中，硫氧还蛋白可以防止雄激素受体诱导的氧化还原损伤, objectType=article, longId=119027, objectId=c48b11902e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c48b11902e69, replyNumber=0, likeNumber=77, createdTime=2017-11-08, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c48b11902e69, moduleTitle=Nat commun：在去势难治性前列腺癌中，硫氧还蛋白可以防止雄激素受体诱导的氧化还原损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c48b11902e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528405, encodeId=e5ba1528405b0, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=CLIN CANCER RES：抗GD2单抗联合化疗以及NK细胞治疗儿童复发或难治性神经母细胞瘤, objectType=article, longId=118954, objectId=24a6118954a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24a6118954a5, replyNumber=0, likeNumber=82, createdTime=2017-11-08, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24a6118954a5, moduleTitle=CLIN CANCER RES：抗GD2单抗联合化疗以及NK细胞治疗儿童复发或难治性神经母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24a6118954a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528404, encodeId=0bb015284048b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Oncogene：雄激素受体调控的脂质合成再激活可促使去势难治性前列腺癌的恶化, objectType=article, longId=118804, objectId=677b1188048a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677b1188048a, replyNumber=0, likeNumber=78, createdTime=2017-11-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677b1188048a, moduleTitle=Oncogene：雄激素受体调控的脂质合成再激活可促使去势难治性前列腺癌的恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677b1188048a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528403, encodeId=bb3c152840392, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAMA Neurol：超声聚焦丘脑切开术可显著缓解药物难治性震颤型帕金森病症状, objectType=article, longId=118647, objectId=bc0e11864e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0e11864e91, replyNumber=0, likeNumber=64, createdTime=2017-11-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0e11864e91, moduleTitle=JAMA Neurol：超声聚焦丘脑切开术可显著缓解药物难治性震颤型帕金森病症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0e11864e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。

2017-12-15

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】II期临床结果表明伊布替尼联合Venetoclax 对复发难治性以及遗传高风险CLL患者效果显著

2017-12-12

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】CLARITY研究——伊布替尼联合Venetoclax疗法对复发难治性CLL患者疗效喜人

2017-12-12

freve (审核中...)

前往app查看评论内容

#难治性#

【2017ASH】PA分析——伊布替尼治疗复发/难治性套细胞淋巴瘤中位随访时间3.5年

2017-12-12

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】伊布替尼治疗复发/难治性套细胞淋巴瘤的长期随访研究

2017-12-12

freve (审核中...)

前往app查看评论内容

#难治性#

JAHA：难治性高血压的患病率和临床特点分析！

2017-12-10

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估

2017-12-08

freve (审核中...)

前往app查看评论内容

#难治性#

NEJM：重症难治性哮喘治疗进展！

2017-12-01

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Respir Med：支气管热成型术治疗和生物治疗可治疗重症难治性哮喘！

2017-12-01

freve (审核中...)

前往app查看评论内容

#难治性#

JAHA：胸段硬膜外麻醉可作为难治性室速的治疗选择

2017-11-24

freve (审核中...)

前往app查看评论内容

#难治性#

难治性高血压患者的新出路

2017-11-23

freve (审核中...)

前往app查看评论内容

#难治性#

病例分享： “微”“难”之处显身手：尼可地尔缓解难治性心绞痛两例

2017-11-20

freve (审核中...)

前往app查看评论内容

#难治性#

Chest：氯法齐明治疗原发性和难治性非结核分枝杆菌感染效果如何？

2017-11-19

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。

2017-11-18

freve (审核中...)

前往app查看评论内容

#难治性#

Eur J Cancer：健康生活品质得分与去势难治性前列腺癌治疗临床结果相关性分析

2017-11-14

freve (审核中...)

前往app查看评论内容

#难治性#

BMJ：1995~2015英国难治性高血压的患病和发病趋势如何？

2017-11-11

freve (审核中...)

前往app查看评论内容

#难治性#

Nat commun：在去势难治性前列腺癌中，硫氧还蛋白可以防止雄激素受体诱导的氧化还原损伤

2017-11-08

freve (审核中...)

前往app查看评论内容

#难治性#

CLIN CANCER RES：抗GD2单抗联合化疗以及NK细胞治疗儿童复发或难治性神经母细胞瘤

2017-11-08

freve (审核中...)

前往app查看评论内容

#难治性#

Oncogene：雄激素受体调控的脂质合成再激活可促使去势难治性前列腺癌的恶化

2017-11-06

freve (审核中...)

前往app查看评论内容

#难治性#

JAMA Neurol：超声聚焦丘脑切开术可显著缓解药物难治性震颤型帕金森病症状

2017-11-05

科室
- - 订阅+
  - 更多科室
工具
服务